Modification of Proteins by Reactive Ethanol Metabolites: Adduct Structure, Functional and Pathological Consequences

Simon Worrall, Geoffrey Milton Thiele

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

This chapter focuses on the modification of proteins by reactive ethanol metabolites and the pathological consequences. Although the exact pathophysiology of Alcoholic Liver Disease (ALD) remains unsolved, there is substantial evidence that altered immune reactivity occurs as a consequence of alcohol ingestion in both humans and animal models. Clinically, the association of circulating autoantibodies, hypergammaglobulinemia, antibodies to unique hepatic proteins, and cytotoxic lymphocytes reacting against autologous hepatocytes, strongly suggests altered immune regulation with a relative loss of self-tolerance. The significant immune responses generated that specifically recognized self-proteins that are modified by metabolites of alcohol, also suggest the significant role that immune reactions may play in inducing and/or sustaining an inflammatory cascade of tissue damage in the liver. While ethanol and its metabolites are too small to act as immunogens, acting as haptens, they could produce changes in the membranes of hepatocytes. Evidence in the favor of this is provided by the demonstration of antibodies reactive with ethanol-altered hepatocytes, and the presence of circulating cytotoxic lymphocytes reactive with autologous hepatocytes. The histological appearances of the various forms of ALD are also suggestive of a chronic active hepatitis-like inflammatory disease.

Original languageEnglish (US)
Title of host publicationComprehensive Handbook of Alcohol Related Pathology
PublisherElsevier Inc.
Pages1209-1222
Number of pages14
Volume3-3
ISBN (Electronic)9780080502311
ISBN (Print)9780125643702
DOIs
StatePublished - Jan 1 2005

Fingerprint

Metabolites
Hepatocytes
Ethanol
Liver
Alcoholic Liver Diseases
Lymphocytes
Proteins
Alcohols
Antigen-antibody reactions
Hypergammaglobulinemia
Self Tolerance
Antibodies
Haptens
Chronic Hepatitis
Autoantibodies
Animals
Demonstrations
Animal Models
Eating
Tissue

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Modification of Proteins by Reactive Ethanol Metabolites : Adduct Structure, Functional and Pathological Consequences. / Worrall, Simon; Thiele, Geoffrey Milton.

Comprehensive Handbook of Alcohol Related Pathology. Vol. 3-3 Elsevier Inc., 2005. p. 1209-1222.

Research output: Chapter in Book/Report/Conference proceedingChapter

Worrall, Simon ; Thiele, Geoffrey Milton. / Modification of Proteins by Reactive Ethanol Metabolites : Adduct Structure, Functional and Pathological Consequences. Comprehensive Handbook of Alcohol Related Pathology. Vol. 3-3 Elsevier Inc., 2005. pp. 1209-1222
@inbook{3ededdbe4c9540f4a3fc656f2175432a,
title = "Modification of Proteins by Reactive Ethanol Metabolites: Adduct Structure, Functional and Pathological Consequences",
abstract = "This chapter focuses on the modification of proteins by reactive ethanol metabolites and the pathological consequences. Although the exact pathophysiology of Alcoholic Liver Disease (ALD) remains unsolved, there is substantial evidence that altered immune reactivity occurs as a consequence of alcohol ingestion in both humans and animal models. Clinically, the association of circulating autoantibodies, hypergammaglobulinemia, antibodies to unique hepatic proteins, and cytotoxic lymphocytes reacting against autologous hepatocytes, strongly suggests altered immune regulation with a relative loss of self-tolerance. The significant immune responses generated that specifically recognized self-proteins that are modified by metabolites of alcohol, also suggest the significant role that immune reactions may play in inducing and/or sustaining an inflammatory cascade of tissue damage in the liver. While ethanol and its metabolites are too small to act as immunogens, acting as haptens, they could produce changes in the membranes of hepatocytes. Evidence in the favor of this is provided by the demonstration of antibodies reactive with ethanol-altered hepatocytes, and the presence of circulating cytotoxic lymphocytes reactive with autologous hepatocytes. The histological appearances of the various forms of ALD are also suggestive of a chronic active hepatitis-like inflammatory disease.",
author = "Simon Worrall and Thiele, {Geoffrey Milton}",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/B978-012564370-2/50094-5",
language = "English (US)",
isbn = "9780125643702",
volume = "3-3",
pages = "1209--1222",
booktitle = "Comprehensive Handbook of Alcohol Related Pathology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Modification of Proteins by Reactive Ethanol Metabolites

T2 - Adduct Structure, Functional and Pathological Consequences

AU - Worrall, Simon

AU - Thiele, Geoffrey Milton

PY - 2005/1/1

Y1 - 2005/1/1

N2 - This chapter focuses on the modification of proteins by reactive ethanol metabolites and the pathological consequences. Although the exact pathophysiology of Alcoholic Liver Disease (ALD) remains unsolved, there is substantial evidence that altered immune reactivity occurs as a consequence of alcohol ingestion in both humans and animal models. Clinically, the association of circulating autoantibodies, hypergammaglobulinemia, antibodies to unique hepatic proteins, and cytotoxic lymphocytes reacting against autologous hepatocytes, strongly suggests altered immune regulation with a relative loss of self-tolerance. The significant immune responses generated that specifically recognized self-proteins that are modified by metabolites of alcohol, also suggest the significant role that immune reactions may play in inducing and/or sustaining an inflammatory cascade of tissue damage in the liver. While ethanol and its metabolites are too small to act as immunogens, acting as haptens, they could produce changes in the membranes of hepatocytes. Evidence in the favor of this is provided by the demonstration of antibodies reactive with ethanol-altered hepatocytes, and the presence of circulating cytotoxic lymphocytes reactive with autologous hepatocytes. The histological appearances of the various forms of ALD are also suggestive of a chronic active hepatitis-like inflammatory disease.

AB - This chapter focuses on the modification of proteins by reactive ethanol metabolites and the pathological consequences. Although the exact pathophysiology of Alcoholic Liver Disease (ALD) remains unsolved, there is substantial evidence that altered immune reactivity occurs as a consequence of alcohol ingestion in both humans and animal models. Clinically, the association of circulating autoantibodies, hypergammaglobulinemia, antibodies to unique hepatic proteins, and cytotoxic lymphocytes reacting against autologous hepatocytes, strongly suggests altered immune regulation with a relative loss of self-tolerance. The significant immune responses generated that specifically recognized self-proteins that are modified by metabolites of alcohol, also suggest the significant role that immune reactions may play in inducing and/or sustaining an inflammatory cascade of tissue damage in the liver. While ethanol and its metabolites are too small to act as immunogens, acting as haptens, they could produce changes in the membranes of hepatocytes. Evidence in the favor of this is provided by the demonstration of antibodies reactive with ethanol-altered hepatocytes, and the presence of circulating cytotoxic lymphocytes reactive with autologous hepatocytes. The histological appearances of the various forms of ALD are also suggestive of a chronic active hepatitis-like inflammatory disease.

UR - http://www.scopus.com/inward/record.url?scp=33444471448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33444471448&partnerID=8YFLogxK

U2 - 10.1016/B978-012564370-2/50094-5

DO - 10.1016/B978-012564370-2/50094-5

M3 - Chapter

AN - SCOPUS:33444471448

SN - 9780125643702

VL - 3-3

SP - 1209

EP - 1222

BT - Comprehensive Handbook of Alcohol Related Pathology

PB - Elsevier Inc.

ER -